. Carbon monoxide produced by isolated arterioles attenuates pressure-induced vasoconstriction. Am J Physiol Heart Circ Physiol 281: H350-H358, 2001.-Studies were conducted on isolated rat gracilis muscle arterioles to examine the role of vascular heme oxygenase (HO)-derived carbon monoxide (CO) on myogenic constrictor responses to stepwise increments in intraluminal pressure. The arterioles express HO-2 but not HO-1 and manufacture CO. Both HO-2 protein expression and CO production are reduced in arterioles maintained for 18 h before experimentation in media containing HO-2 antisense oligodeoxynucleotides (AS-ODN). Pressurization of arterioles mounted on a myograph over the pressure range of 40-100 mmHg elicits reduction of internal diameter. At pressures Ͼ40 mmHg, the internal diameter of vessels treated with either HO-2 AS-ODN, the HO inhibitor chromium mesoporphyrin (CrMP), or the K ϩ channel blocker tetraethylammonium (TEA) are smaller than the corresponding control values. The inclusion of exogenous CO, but not of biliverdin, in the superfusion buffer attenuates pressure-induced vasoconstriction in CrMP-treated vessels. However, exogenous CO does not attenuate pressure-induced vasoconstriction in vessels treated with both CrMP and TEA. Collectively, these data suggest that CO of vascular origin attenuates pressureinduced arteriolar constriction via a mechanism involving a TEA-sensitive K ϩ channel.
CARBON MONOXIDE (CO) is a product of heme metabolism by heme oxygenase (HO) isoforms 1 and 2 (16, 25) . Exogenous CO relaxes vascular smooth muscle and promotes vasodilation (6, 17, 22) . Depending on the vascular preparation, these actions of CO have been linked to activation of soluble guanylate cyclase (4, 19) , stimulation of calcium-activated potassium (K Ca ) channels (25) (26) (27) , or inhibition of endothelin release from endothelial cells (5, 18) .
Arterial vessels express HO-2 constitutively (14, 16, 25) , whereas HO-1 is primarily expressed in settings that promote induction of its gene (9, 20) . Moreover, arterial vessels manufacture CO (6, 20) . CO of vascular origin is thought to subserve a vasodilatory function, based on reports that metalloporphyrins that inhibit HO bring about vasoconstriction (5, 14) or increased vascular reactivity to constrictor agonists (3, 13, 20) . However, this conclusion is tentative, because the specificity of HO inhibition with metalloporphyrins has been challenged (8, 23) .
According to a recent study, metalloporphyrins with HO inhibitory properties constrict pressurized rat gracilis muscle arterioles, an effect attributed to magnification of myogenic tone (14) . The present study was designed to examine the hypothesis that CO of vascular origin modulates myogenic constrictor responses to increments in intraluminal pressure. To this end, we conducted experiments in rat gracilis muscle arterioles with three goals in mind: 1) to quantify the generation of CO and determine whether or not it is HO dependent; 2) to examine the effect of interventions that decrease the activity or expression of HO on the intraluminal pressure-arteriolar diameter relationship; and 3) to investigate involvement of K Ca channels in the action of HO-derived CO on myogenic vasoconstriction.
MATERIALS AND METHODS
Chemicals. Chromium mesoporphyrin (CrMP) and biliverdin were purchased from Porphyrin Products (Logan, UT), and stock solutions were prepared in 50 mmol/l Na 2CO3. CO was purchased from Tech Air (White Plains, NY), and COsaturated solution (1 mmol/l) was prepared shortly before use (14) . Polyclonal HO-1 and HO-2 antibodies were obtained from Stress Gen (Victoria, BC, Canada) and other chemicals from Sigma (St. Louis, MO).
Animals. All animal protocols were approved by the Institutional Animal Care and Use Committee of New York Medical College. Male Sprague-Dawley rats (250-300 g, Charles River; Wilmington, DE) were anesthetized with pentobarbital sodium (60 mg/kg ip), and the gracilis anticus muscles were removed and placed on a dish filled with ice-cold Krebs buffer composed of (in mmol/l) 118.5 NaCl, 4.7 KCl, 2.5 CaCl 2, 1.2 KH2PO4, 1.2 MgSO4, 25.0 NaHCO3, and 11.1 dextrose. First-order gracilis muscle arterioles were dissected for use in studies examining 1) the effect of interventions that decrease the expression and/or activity of HO on arteriolar CO generation and on the relationship between intraluminal pressure and the internal diameter of arterioles, and 2) the involvement of vascular smooth muscle K Ca channels in the action of CO on myogenic constrictor responsiveness.
Evaluation of the pressure-diameter relationship Segments (1-2 mm length) of first-order gracilis muscle arterioles, either pretreated as described below or freshly prepared, were transferred to a water-jacketed vessel chamber (1-ml volume) filled with Krebs buffer containing the nitric oxide synthase inhibitor N -nitro-L-arginine methyl ester (L-NAME, 1 mmol/l) to avoid the confounding influence on interpretation of results of interactions between the nitric oxide and CO systems (16, 22) . One end of the vessel was mounted on a glass micropipette connected to a pressure servocontroller (model CH/200/Q, Living System Instrumentation; Burlington, VT). Subsequently, the vessel was flushed to remove residual blood and the other end of the vessel was mounted on a micropipette connected to a stopcock. The vessel chamber was placed on the stage of a microscope fitted with a video camera (Javelin; Newburgh, NY) leading to a video caliper (Texas A & M, College Station, TX), monitor (Javelin), and recorder. Unless indicated otherwise, the vascular preparation was superfused throughout (1 ml/min at 37°C) with L-NAME-containing Krebs buffer gassed with 95% O 2-5% CO2. After the stopcock was closed, the intraluminal pressure was increased slowly to 80 mmHg, and the level of pressure was maintained during a 60-min equilibration period. Only vessels that developed spontaneous tone during equilibration were utilized.
The intraluminal pressure-internal diameter relationship was studied as described previously (21) . Following equilibration, the pressure was decreased to about 0 mmHg, and, after 10 min, it was increased in 20-mmHg steps until it reached 100 mmHg. The pressure was maintained for about 5-10 min at each pressure step so that vessels could reach a steady-state diameter. Before an experiment was concluded, the vascular preparation was superfused with calcium-free Krebs buffer containing 1 mmol/l EGTA and 1 mmol/l L-NAME, and the pressure-diameter relationship was examined again to obtain the passive diameter of the vessel at each level of intraluminal pressure. The internal arteriolar diameter during superfusion of the vascular preparation with calcium-containing buffer (absolute diameter) and with calcium-free buffer (passive diameter) are expressed in micrometers. The normalized diameter refers to the absolute diameter expressed as percentage of the passive diameter. The following experimental protocols were implemented.
In protocol 1, the pressure-diameter relationship in vessels pretreated with antisense oligodeoxynucleotides (AS-ODN), which interfere with HO-1 or HO-2 expression, was compared with that in vessels pretreated with the corresponding scrambled (S)-ODN. AS-ODN complementary to rat HO-1 mRNA (HO-1 AS-ODN) and rat HO-2 mRNA (HO-2 AS-ODN), as well as the corresponding S-ODN (HO-1 S-ODN and HO-2 S-ODN), were synthesized and purified by Genosys Biotechnologies (Woodland, TX). Each ODN was phosphorothioated on the first three bases of the 3Ј end. The sequence of HO-1 AS-ODN is 5Ј-GGCGCTCCATCGCGGGACTG-3Ј and targets bases ϩ10 to Ϫ9 of HO-1 mRNA, and the sequence of HO-2 AS-ODN is 5Ј-TCTGAAGACATTGTT-GCTGA-3Ј and targets bases ϩ11 to Ϫ9 of HO-2 mRNA. The sequence of HO-1 S-ODN is 5Ј-TCCAGCGGCGTCAGCG-GTGC-3Ј, and the sequence of HO-2 S-ODN is 5Ј-GATCT-GACTTCAAGTGATTG-3Ј. Before use, the ODNs were encapsulated in cationic liposomes (1 g oligodeoxynucleotide/1 g liposome) prepared using N- [1-(2,3-dioleoyloxy) propyl]-N,N,N-trimethylammonium methylsulfate (BoehringerMannheim; Indianapolis, IN). The effectiveness of HO-1 AS-ODN and HO-2 AS-ODN in reducing tissue expression of HO-1 and HO-2, respectively, was documented previously (1) . Freshly dissected gracilis muscle arterioles were placed on culture dishes (35 mm) containing tissue culture medium only (Dulbecco's modified Eagle's medium with 10% Nuserum, 100 g/ml streptomycin, and 100 g/ml penicillin) or tissue culture medium plus either HO-1 AS-ODN, HO-2 AS-ODN, or the corresponding S-ODN (all at 40 g/ml). After incubation for 18 h at 37°C in an atmosphere of 95% air-5% CO2, the pressure-diameter relationship was studied as detailed above. But it is conceivable that the functional response to an intervention that selectively interferes with HO-2 expression is negated by reciprocal changes in function brought about by compensatory induction of HO-1 (16) . Therefore, additional experiments were conducted to examine the pressure-diameter relationship in vascular preparations treated with both HO-1 AS-ODN and HO-2 AS-ODN combined. The pressure-diameter relationship in vessels pretreated with both HO-1 AS-ODN and HO-2 AS-ODN also was examined after the addition of exogenous CO (1-10 mol/l) to the superfusion buffer.
In protocol 2, the pressure-diameter relationship was studied in freshly isolated gracilis muscle arterioles superfused with buffer either containing or not containing CrMP (15 mol/l), an inhibitor of HO-1 and HO-2 (23). The pressure-diameter relationship also was examined in vessels superfused with buffer containing CrMP (15 mol/l) along with either exogenous CO (1-100 mol/l) or biliverdin (10 mol/l).
In protocol 3, the pressure-diameter relationship was studied in freshly isolated gracilis muscle arterioles superfused with buffer either containing or not containing tetraethylammonium (TEA, 1.0 mmol/l), a relatively selective blocker of K Ca channels (2). The pressure-diameter relationship was also examined in vessels superfused with buffer containing TEA (1.0 mmol/l), CO (100 mol/l), and/or CrMP (15 mol/l).
Patch-clamp studies. The effect of the HO inhibitor CrMP (15 mol/l) and CO (10 mol/l) on K ϩ channel currents was studied in smooth muscle cells isolated from gracilis muscle arterioles (11) . Patch-clamp studies were conducted within 4 h of completing isolation of the vascular smooth muscle cells (11, 15) . K ϩ currents were recorded using the cellattached and the inside-out and outside-out patch configurations. The pipette solution contained (mmol/l) 140 KCl, 1.8 MgCl2, and 10 HEPES (pH 7.4). The composition of the pipette solution used in outside-out patches was the same as above except that the concentration of CaCl2 was 10 mol/l. The composition of the bath solution used in experiments with cell-attached patches was (in mmol/l) 140 NaCl, 5 KCl, 1.8 MgCl2, 1.8 CaCl2, 0.1 8-bromo-cGMP, and 10 HEPES (pH 7.4). The composition of the bath solution used in inside-out patches was the same as above except that the concentration of CaCl2 was varied between 0 and 1 mol/l. 8-Bromo-cGMP was included in the bath solution to boost the activity of K ϩ channels, which under resting conditions is low (11) . The open-state probability (NP 0) was calculated from data sampled over a 30-to 60-s interval in the steady state, during control and experimental periods. The following equation was used
where ti is the fractional open time spent at each of the observed current levels. Single-channel K ϩ currents recorded from inside-out membrane patches excised from gracilis arteriole smooth muscle cells were characterized by their current-voltage relationship, their susceptibility to activation by 
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Ca 2ϩ in the bath, and their response to treatment with TEA (1 mmol/l). We also examined, using outside-out patches, the effect of iberiotoxin (100 nmol/l) on channel activity in the presence of 10 mol/l Ca 2ϩ (facing the cytoplasmic membrane).
Analysis of HO proteins and CO release. HO-1 and HO-2 protein expression was assessed in pooled gracilis muscle arterioles (vessels from 10 rats in each pool) incubated for 18 h as detailed above in tissue culture medium containing either HO-2 AS-ODN or HO-2 S-ODN (both at 40 g/ml). The vessels were homogenized, the homogenate was centrifuged, and the 10,000 g supernatant was analyzed for HO-1 and HO-2 protein by immunoblotting as previously described (14) .
Gracilis muscle arterioles maintained for 18 h in culture media containing HO-2 AS-ODN or HO-2 S-ODN were compared by ability to release CO. Vessels so treated were transferred into amber glass vials (2 ml) containing 1.0 ml of Krebs buffer saturated with 95% O 2-5% CO2, the vials were capped tightly with rubberized Teflon liners, and the samples were incubated at 37°C for 60 min. The incubations were terminated by placement of the samples on ice. Subsequently, internal standards made of isotopically labeled CO ( 13 C 16 O and 13 C 18 O) were injected into samples, and the CO content of the headspace gas was determined by gas chromatography/mass spectroscopy. Release of CO was also studied in freshly isolated gracilis muscle arterioles incubated (1 h) as described above in Krebs buffer either containing or not containing CrMP (15 mol/l). The analyses of CO were performed using a HP-5989A mass spectrometer interfaced to a HP-5890 gas chromatograph. The separation of CO from other gases was carried out on a GS-Molesieve capillary column (30 m, 0.53-mm internal diameter) (J&W Scientific; Folsom, CA) kept at 40°C. Helium was used as the carrier gas with a linear velocity of 0.3 m/s. CO eluted at 3.6 min and was fully separated from N 2, O2, H2O, and CO2. The mass spectrometer parameters were 120°C ion source temperature, 31 eV electron energy, and 120°C transfer line temperature. Aliquots (100 l) of the headspace gas of either standard solutions or experimental samples were injected using a gas-tight syringe into the spitless injector having a temperature of 120°C. Abundance of ions at 28, 29, and 31 mass-tocharge ratio (m/z) corresponding to Data analysis. Data are expressed as means Ϯ SE. Data of the pressure-diameter relationship in different groups of vessels were compared by ANOVA followed by the NewmanKeuls post hoc analysis to isolate differences at various levels of pressure. Student's t-test was used to compare data on CO release. The null hypothesis was rejected at P Ͻ 0.05.
RESULTS

CO production and HO expression in gracilis muscle
arterioles. Western blot analysis of proteins in homogenates of pooled gracilis muscle arterioles maintained in organ culture for 18 h revealed a protein with the molecular mass of HO-2, but a protein with the molecular mass of HO-1 was not detected (Fig. 1) . The expression of HO-2 protein in vessels maintained in media containing HO-2 AS-ODN appears to be reduced compared with that in vessels maintained in media containing HO-2 S-ODN (Fig. 1) . Gracilis muscle arterioles released CO into the headspace during incubation in Krebs buffer (Fig. 1) . CO release from vessels maintained in media containing HO-2 AS-ODN was less (P Ͻ 0.05) than that from vessels maintained in media containing HO-2 S-ODN (Fig. 1) .
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, n ϭ 4 experiments). Effect of interventions that decrease CO production on the pressure-diameter relationship in gracilis muscle arterioles. Figure 2 displays data on internal diameter as a function of intraluminal pressure in arterioles maintained for 18 h before experimentation in culture media with and without HO-1 AS-ODN, HO-2 AS-ODN, both HO-1 AS-ODN and HO-2 AS-ODN, or the corresponding S-ODN. Increments of pressure over the range of 0-40 mmHg increased (P Ͻ 0.05) the absolute diameter in all the groups but had little or no effect on the normalized diameter. Further stepwise increments in pressure to a maximum of 100 mmHg brought about reductions (P Ͻ 0.05) in both the absolute and the normalized diameter. Neither the absolute diameter nor the normalized diameter of vessels treated with HO-1 AS-ODN differed from the corresponding values in untreated vessels or in vessels treated with HO-1 S-ODN over the pressure range of 0-100 mmHg. Similarly, at low intraluminal pressures, both the absolute diameter and the normalized diameter of vessels treated with HO-2 AS-ODN or with both HO-1 AS-ODN and HO-2 AS-ODN did not differ from matching data in untreated vessels or in vessels treated with the corresponding S-ODN. In contrast, at pressures Ͼ40 mmHg, the absolute diameter and the normalized diameter of vessels treated with HO-2 AS-ODN or with both HO-1 AS-ODN and HO-2 AS-ODN were smaller (P Ͻ 0.05) than the corresponding values in untreated vessels or in vessels treated, respectively, with HO-2 S-ODN or with HO-1 S-ODN and HO-2 S-ODN combined. It appears, then, that treatment of vessels with HO-2 AS-ODN or with both HO-1 AS-ODN and HO-2 AS-ODN accentuates the constrictor response to increments in intraluminal pressure over the range of 40-100 mmHg. As shown in Fig. 3 , in vessels pretreated with both HO-1 AS-ODN and HO-2 AS-ODN, the inclusion of CO (1-10 mol/l) in the superfusion buffer attenuated the pressure-induced reduction of both the absolute and the normalized diameter over the pressure range of 40-100 mmHg. Figure 4 displays data on the pressure-diameter relationship in freshly dissected arterioles superfused with buffer only or with buffer containing the HO inhibitor CrMP (15 mol/l) alone and combined with either CO (1-100 mol/l) or biliverdin (10 mol/l). The absolute diameter of untreated arterioles increased (P Ͻ 0.05) in response to increments of intraluminal pressure over the range of 0-40 mmHg, but the normalized diameter did not change; further pressure increments to a maximum of 100 mmHg elicited reduction (P Ͻ 0.05) in both the absolute and the normalized diameter. The absolute diameter of CrMP-treated vessels did not change appreciably when the intraluminal pressure was increased to 20 mmHg, but further increments of pressure elicited striking reduction (P Ͻ 0.05) of both the absolute and the normalized diameter. The absolute diameter and the normalized diameter of CrMP-treated vessels at pressure Ͼ20 mmHg were smaller (P Ͻ 0.05) than the corresponding data in untreated vessels. The amplifying effect of CrMP treatment on pressure-induced reductions of absolute and normalized diameter was not modified by the inclusion of biliverdin (10 mol/l) into the superfusion buffer. In contrast, the inclusion of exogenous CO (10 or 100 mol/l) in the superfusion buffer attenuated (P Ͻ 0.05), in a concentration-dependent manner, the pressureinduced reduction of both absolute and normalized diameter in CrMP-treated arterioles. Figure 5 depicts the pressure-diameter relationship in freshly dissected arterioles superfused with buffer only or with buffer containing either the K Ca channel blocker TEA (1.0 mmol/l) alone, both TEA and CrMP, or TEA combined with CrMP and exogenous CO (100 mol/l). Increasing intraluminal pressure over the range of 0-40 mmHg increased (P Ͻ 0.05) the absolute diameter of both untreated and TEA-treated vessels, but the normalized diameter was not affected in the former and decreased (P Ͻ 0.05) in the latter vessels. Further increments of pressure over the range of 40-100 mmHg prompted reductions (P Ͻ 0.05) in the absolute and the normalized diameter of both untreated and TEA-treated vessels. The absolute diameter and the normalized diameter of TEA-treated arterioles at pressures Ͼ20 mmHg were surpassed (P Ͻ 0.05) by the corresponding data in untreated vessels. Pressure-induced vasoconstriction in TEA-treated vessels was not enhanced further by concurrent treatment with CrMP, nor was it attenuated by the inclusion of exogenous CO (100 mol/l) in the superfusion buffer.
Effect of HO inhibition on K ϩ channel currents in gracilis arteriole smooth muscle cells. Figure 6 shows single K ϩ currents recorded from inside-out patches of smooth muscle cells. In four experiments in which K ϩ channel currents were recorded from a holding potential of Ϫ10 mV to 10 mV, the single-channel slope conductance was 105 Ϯ 5 pS (Fig. 6A) . K ϩ channel currents were absent from patches bathed in Ca 2ϩ -free solution and reappeared when Ca 2ϩ was reintroduced (Fig. 6B) . The inclusion of TEA (1 mmol/l) into the solution facing the cytoplasmic side of the patch decreased K ϩ channel activity; it also reduced the channel current amplitude, which is a characteristic of the TEA-induced fast blockade (Fig. 6C) . K ϩ channel activity recorded in outside-out patches was decreased by Fig. 4 . Effect of stepwise increment in intraluminal pressure on the absolute and the normalized ID of first-order gracilis muscle arterioles superfused with buffer only (control), with buffer containing chromium mesoporphyrin (CrMP), or with buffer containing CrMP plus biliverdin or CO. Data are means Ϯ SE. *P Ͻ 0.05 relative to data in vessels superfused with buffer only. Numbers in parentheses indicate the number of rats. Fig. 3 . Effect of stepwise increments in intraluminal pressure on the absolute and the normalized ID of first-order gracilis muscle arterioles maintained for 18 h before experimentation in culture media containing HO-1 AS-ODN and HO-2 AS-ODN. Comparisons were made in vessels superfused with buffer either with or without exogenous CO. Data are means Ϯ SE. *P Ͻ 0.05 relative to corresponding data in vessels superfused with buffer without exogenous CO. Numbers in the parentheses indicate the number of rats. the inclusion of iberiotoxin (100 nmol/l) into the solution in contact with the extracellular side of the excised patch (Fig. 6D) .
The effect of CrMP on K ϩ channel activity recorded from cell-attached patches is illustrated in Fig. 7 . CrMP reduced channel activity and decreased NP o from 1.05 Ϯ 0.10 to 0.10 Ϯ 0.02 (n ϭ 9 experiments; P Ͻ 0.05). In the face of continuous exposure of the cells to CrMP, the addition of exogenous CO to the bath restored NP o to near-control values (0.94 Ϯ 0.1; P Ͻ 0.05). CrMP did not affect K ϩ channel activity in inside-out membrane patches exposed to media containing 10 mol/l Ca 2ϩ (NP o , 0.75 Ϯ 0.05 control vs. 0.74 Ϯ 0.05 with CrMP, n ϭ 3 experiments).
DISCUSSION
CO is produced in tissues via HO-dependent and HO-independent pathways (24) . We found that gracilis muscle arterioles incubated in Krebs buffer release CO. The CO released from these vessels is primarily manufactured via a HO-dependent pathway, because treatment of the vessels with the HO inhibitor CrMP decreased CO release to about 16% of control. Gracilis muscle arterioles express HO-2 but not HO-1 in the basal state (14) . Our study shows that HO-2 protein expression is decreased in arterioles maintained under culture conditions for 18 h in media containing HO-2 AS-ODN. Moreover, the release of CO from vessels treated with HO-2 AS-ODN is reduced compared with that from vessels treated with HO-2 S-ODN. Collectively, these observations indicate that HO-2 contributes to the manufacture of CO in gracilis muscle arterioles in the basal state. Under special circumstances, HO-1 also contributes to generation of CO in vascular tissue. For example, CO production is increased in the aorta of rats subjected to conditions that bring about induction of vascular HO-1 (20) .
Previous studies (21) documented that stepwise increments in intraluminal pressure over the range of 40-120 mmHg bring about constriction of isolated rat gracilis muscle arterioles via a mechanism intrinsic to the smooth muscle of arterioles. We found that pressure-induced constrictor responses are magnified in vessels treated with either CrMP, HO-2 AS-ODN, or both HO-1 AS-ODN and HO-2 AS-ODN. Treatment with CrMP also decreased the threshold for expression of pressure-induced arteriolar constriction. In contrast, pressure-induced constrictor responses were not enhanced by treatment with either HO-1 AS-ODN, HO-1 S-ODN, or HO-2 S-ODN. These results suggest that reduction of HO-2 expression or activity brings about intensification of vasoconstrictor responses to increments in pressure. Such intensification of pressureinduced arteriolar constriction may be the manifestation of diminished vascular production of a HO-2 product that exerts a tonic inhibitory influence of myogenic vasoconstriction.
In our study, pressure-induced constrictor responses in gracilis muscle arterioles superfused with buffer containing CrMP alone were equally magnified as in vessels superfused with buffer containing both CrMP and the HO product biliverdin (10 mol/l). In contrast, pressure-induced constrictor responses in vessels treated with CrMP were attenuated by the inclusion of CO (10 and 100 mol/l) into the superfusion buffer. Inclusion of CO (1 and 10 mol/l) into the superfusion buffer also decreased the intensity or pressure-induced constrictor responses in vessels treated with both HO-1 AS-ODN and HO-2 AS-ODN. These observations suggest that CO, rather than biliverdin, is the product of heme metabolism by vascular HO-2, which inhibits myogenic vasoconstriction. A preliminary study suggested that CO of vascular origin also attenuates the sensitivity of rat renal interlobar arteries to phenylephrine (13) . Therefore, vascular CO may be the key protagonist of a regulatory mechanism that reduces the reactivity of vascular smooth muscle to both myogenic and hormonal stimuli. In accord with this notion, other investigators have reported that the reactivity to constrictor agonists is decreased in rat aortas and tail arteries subjected to conditions that induce HO-1 expression (3, 20, 25, 26) .
In the present study, treatment of gracilis arteriole smooth muscle cells with CrMP reduced the NP o of a 105-pS K ϩ channel requiring Ca 2ϩ for activation and inhibited by TEA and iberiotoxin. That CrMP did not reduce the activity of this channel in inside-out membrane patches of smooth muscle cells argues against direct inhibition of the channel by the HO inhibitor. Rather, the inhibitory effect of CrMP on K ϩ channel activity of cell-attached patches may be due to diminished synthesis of HO-derived CO. This is supported by the observation that exogenous CO increased the open probability of the 105-pS K ϩ channel in smooth muscle cells pretreated with CrMP, reversing the effect of the HO inhibitor. Previously, other investigators demonstrated that exogenous CO stimulates a 238-pS K Ca channel in smooth muscle cells of rat tail artery by increasing the calcium sensitivity of this high-conductance channel (27) . Collectively, these observations suggest that CO produced in vascular smooth muscle cells stimulates K channels activated by Ca 2ϩ and inhibited by TEA and iberiotoxin.
Previous studies (2, 10) have suggested participation of K Ca channels in the regulation of membrane potential and tone in small myogenically active arteries studied in vitro. For example, blockade of K Ca channels with TEA was reported to bring about depolarization and constriction of pressurized cerebral arteries (2) . The constrictor response to TEA was attributed to enhancement of myogenic tone, reflecting interference with the function of a negative feedback pathway involving K Ca channels, which controls the degree of membrane depolarization and, consequently, the level of myogenic tone (2) . Our present in vitro study of gracilis muscle arterioles provides evidence consistent with such an inhibitory influence of K Ca channels on myogenic vasoconstriction. We found that the inclusion of TEA into the superfusion buffer greatly increased the sensitivity and the intensity of the constrictor response to increments in pressure, mimicking the effect of CrMP on the pressure-diameter relationship. Because treatment of gracilis arteriole smooth muscle cells with CrMP decreases the activity of a 105-pS K ϩ channel sensitive to TEA, the possibility arises that the intensification of pressure-induced constrictor responses in vessels treated with CrMP is linked to reduction in the NP o of K Ca channels in vascular smooth muscle due to a decrease in CO production. In this regard, we found that pressure-induced constrictor responses were equally increased by treatment of the vessels with TEA alone or with both TEA and CrMP concurrently, which is consistent with a common mechanism accounting for the effects of TEA and the HO inhibitor on the pressure-diameter relationship. We also found that the inclusion of exogenous CO (100 mol/l) into the superfusion buffer did not attenuate pressure-induced constriction in vessels treated with both TEA and CrMP. Altogether, these results suggest that CO of vascular origin attenuates pressure-induced vasoconstriction via a mechanism that involves K Ca channels. These findings relate to the developing concept that endogenous CO plays a role in the regulation of vascular tone and blood pressure (12) .
In summary, this study provides information on the generation of CO by rat gracilis muscle arterioles, the influence of endogenous CO on pressure-induced vasoconstriction, and the involvement of K ϩ channels in the modulatory action of CO on myogenic vasoconstriction. We found that gracilis muscle arterioles manufacture CO via a HO-2-dependent pathway, which in turn, reduces pressure-induced vasoconstriction by activating K Ca channels in vascular smooth muscle. On the basis of these findings, it is tempting to speculate that CO manufactured by resistance vessels participates in the regulation of vascular tone and tissue perfusion by serving as an endogenous activator of K Ca channels in vascular smooth muscle, thus exerting an inhibitory influence on the reactivity of vascular smooth muscle to constrictor stimuli. But the extrapolation of conclusions derived from our studies in vitro to more physiological settings in vivo can be challenged on several grounds. K Ca channels were reported not to play a role in the regulation of myogenic tone in cremaster muscle arterioles in vivo (11) and, therefore, may not be targets for an inhibitory action of endogenous CO on myogenic vasoconstriction in vivo. The regulatory effectiveness of arteriolar CO in vivo may be reduced by the presence of red blood cell hemoglobin that scavenges CO. In physiological settings where endothelial cell nitric oxide synthesis undergoes tonic stimulation by shear stress, arteriolar CO may exert an inhibitory action on endothelial nitric oxide synthase that brings about vasoconstriction rather than vasodilation (22) . These are among the issues that need to be addressed in the future to gain a fuller appreciation of the role of CO of vascular origin in the regulation of vasomotor tone in vivo.
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